Winslow Evans & Crocker’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $63K | Hold |
403
| – | – | 0.01% | 548 |
|
|
2020
Q3 | $47K | Hold |
403
| – | – | 0.01% | 471 |
|
|
2020
Q2 | $45K | Sell |
403
-1
| -0.2% | -$112 | 0.01% | 478 |
|
|
2020
Q1 | $38K | Hold |
404
| – | – | 0.01% | 476 |
|
|
2019
Q4 | $46K | Hold |
404
| – | – | 0.01% | 523 |
|
|
2019
Q3 | $42K | Hold |
404
| – | – | 0.01% | 532 |
|
|
2019
Q2 | $56K | Sell |
404
-12
| -3% | -$1.66K | 0.02% | 489 |
|
|
2019
Q1 | $58K | Buy |
416
+12
| +3% | +$1.67K | 0.02% | 469 |
|
|
2018
Q4 | $42K | Hold |
404
| – | – | 0.01% | 495 |
|
|
2018
Q3 | $58K | Hold |
404
| – | – | 0.02% | 459 |
|
|
2018
Q2 | $52K | Hold |
404
| – | – | 0.02% | 488 |
|
|
2018
Q1 | $44.9K | Hold |
404
| – | – | 0.01% | 503 |
|
|
2017
Q4 | $48.2K | Hold |
404
| – | – | 0.02% | 500 |
|
|
2017
Q3 | $56.5K | Buy |
404
+1
| +0.2% | +$140 | 0.02% | 451 |
|
|
2017
Q2 | $49K | Sell |
403
-1
| -0.2% | -$122 | 0.01% | 560 |
|
|
2017
Q1 | $48.9K | Hold |
404
| – | – | 0.02% | 542 |
|
|
2016
Q4 | $49.3K | Hold |
404
| – | – | 0.02% | 539 |
|
|
2016
Q3 | $49.4K | Buy |
404
+250
| +162% | +$30.6K | 0.01% | 543 |
|
|
2016
Q2 | $17.9K | Buy |
154
+1
| +0.7% | +$116 | 0.01% | 724 |
|
|
2016
Q1 | $21.3K | Sell |
153
-1
| -0.6% | -$139 | 0.01% | 689 |
|
|
2015
Q4 | $29.2K | Hold |
154
| – | – | 0.01% | 655 |
|
|
2015
Q3 | $23.9K | Hold |
154
| – | – | 0.01% | 676 |
|
|
2015
Q2 | $27.7K | Hold |
154
| – | – | 0.01% | 687 |
|
|
2015
Q1 | $26.5K | Sell |
154
-2,710
| -95% | -$467K | 0.01% | 671 |
|
|
2014
Q4 | $530K | Buy |
2,864
+2,710
| +1,760% | +$501K | 0.15% | 153 |
|
|
2014
Q3 | $25.4K | Buy |
154
+1
| +0.7% | +$165 | 0.01% | 687 |
|
|
2014
Q2 | $23.9K | Hold |
153
| – | – | 0.01% | 636 |
|
|
2014
Q1 | $23.3K | Hold |
153
| – | – | 0.01% | 633 |
|
|
2013
Q4 | $20K | Buy |
+153
| New | +$20K | 0.01% | 708 |
|